跳至主要内容
临床试验/NL-OMON41588
NL-OMON41588已完成不适用

Discrimination of benign and malignant human tissue during percutaneous interventions using optical spectroscopy techniques - Optical detection of malignancy during percutaneous interventions

Philips Research0 个研究点目标入组 106 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
106

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1) Patients with a suspicious lesion in breast, lung or liver who are scheduled for a standard core biopsy procedure
  • 2) Patient planned for percutaneous RFA of colorectal liver metastasis
  • 3) Written informed consent
  • 4) Patients >= 18 years old
  • 5) Breast patients with a BIRADS score 4 or 5

排除标准

  • 1) Patients who have high risk of bleeding
  • 2) Patients with suspected sensitivity to light; e.g. patients who have had photodynamic therapy
  • 3) Patients who have a history of breast cancer and/or who have received prior chemotherapy, endocrine therapy, or radiation therapy
  • 4) Patients who have breast implants
  • 5) Patients needing a stereotactic breast biopsy (i.e. non palpable-, ultrasound opaque lesions)

研究者

相似试验

Discrimination of benign and malignant human tissue... | 临床试验